ProShare Advisors LLC Purchases 29,750 Shares of Intuitive Surgical, Inc. $ISRG

ProShare Advisors LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 556,570 shares of the medical equipment provider’s stock after acquiring an additional 29,750 shares during the quarter. Intuitive Surgical accounts for approximately 0.6% of ProShare Advisors LLC’s investment portfolio, making the stock its 23rd biggest holding. ProShare Advisors LLC owned approximately 0.16% of Intuitive Surgical worth $302,446,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. TD Capital Management LLC grew its holdings in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. 1248 Management LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $30,000. Bank of Jackson Hole Trust increased its holdings in shares of Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 31 shares during the last quarter. Finally, CBIZ Investment Advisory Services LLC lifted its holdings in Intuitive Surgical by 49.1% during the 1st quarter. CBIZ Investment Advisory Services LLC now owns 82 shares of the medical equipment provider’s stock valued at $41,000 after purchasing an additional 27 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, VP Fredrik Widman sold 2,067 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total value of $1,136,850.00. Following the transaction, the vice president directly owned 473 shares of the company’s stock, valued at $260,150. The trade was a 81.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 98,078 shares of company stock valued at $51,445,892 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of several research analyst reports. Robert W. Baird set a $655.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Sanford C. Bernstein reiterated an “outperform” rating and set a $685.00 target price on shares of Intuitive Surgical in a research note on Tuesday, October 21st. BTIG Research upped their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Argus lifted their target price on Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Finally, HSBC upped their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Trading Up 2.2%

Shares of NASDAQ:ISRG opened at $560.00 on Monday. The firm has a 50 day moving average of $471.89 and a 200-day moving average of $501.11. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a market capitalization of $200.75 billion, a PE ratio of 74.07, a PEG ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the company earned $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.